NCT06188611

A Phase IV Study of Huazhi Rougan Granule

A Placebo Control, Randomized, Double-blind, Multicenter Phase IV Study to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver (Damp-heat Obstruction Syndrome: Shi-Re-Zhong-Zu Zheng)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 282 (actual)
• Sponsor: Shandong New Time Pharmaceutical Co., LTD · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A Placebo control, Randomized, Double-blind, Multicenter Phase IV study to investigate the efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic simple fatty liver (damp-heat obstruction syndrome: Shi-Re-Zhong-Zu Zheng)

Conditions

• A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Interventions

Type	Name	Description
DRUG	Huazhi Rougan Granule Placebo granule	Experimental: Huazhi Rougan granule Placebo Comparator: Placebo granule Placebo Comparator: Placebo granule

Timeline

• Start date: 2017-05-18
• Primary completion: 2018-11-08
• Completion: 2018-11-08
• First posted: 2024-01-03
• Last updated: 2024-01-03

Locations

1 site across 1 country: China